<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01011387</url>
  </required_header>
  <id_info>
    <org_study_id>NPWT 01</org_study_id>
    <nct_id>NCT01011387</nct_id>
  </id_info>
  <brief_title>Evaluation of Negative Pressure Wound Therapy in the Treatment of DFUs Incl. Post Amputation Wounds.</brief_title>
  <official_title>A Prospective, Open, Non-controlled Clinical Investigation to Evaluate a NPWT (Negative Pressure Wound Therapy) System to be Used in the Treatment of Diabetic Foot Ulcers (DFUs) Including Post Amputation Wounds Associated With Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Primary objective

        -  To assess wound healing and granulation tissue formation when using the NPWT system

      Secondary objectives

        -  To investigate the pain level at dressing removal

        -  To visually check exudate removal

        -  To investigate the ease of use for the subject and care giver when using the NPWT system
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigation is designed as a prospective, open, non-controlled clinical investigation.

      Wounds to be treated under this protocol should be Diabetic foot ulcers (DFUs) or post
      amputation wounds associated with diabetes in hospitalized subjects or subjects treated at
      home. One ulcer or post amputation wound per subject will be treated for a maximum duration
      of 4 weeks. All subjects will receive negative pressure treatment with the NPWT system, -120
      mm Hg.

      In total, 10-15 subjects at two sites will be enrolled provided that they fulfill all the
      inclusion criteria and none of the exclusion criteria and have signed and dated a written
      informed consent.

      The subjects will be consecutively allocated to a specific subject identification code and
      the recruitment will be competitive.

      The primary variable wound healing and granulation tissue formation will be assessed by
      digital planimeter, digital photography and visual estimation.

      Pain level and subject/investigator convenience will be assessed by convenience surveys.

      An evaluable subject is defined as a subject completing the investigation with 4 weeks of
      treatment, a subject healed before 4 weeks of treatment or if the investigator judge that the
      wound has adequately responded on NPWT before 4 weeks and that continued treatment can be
      made with alternative treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">July 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Change in Wound Area.</measure>
    <time_frame>From baseline to maximum 4 weeks</time_frame>
    <description>Measured by tracing of wound and measured by planimeter.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Diabetes</condition>
  <condition>Foot Ulcers</condition>
  <arm_group>
    <arm_group_label>NPWT system</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Negative pressure wound therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>NPWT System</intervention_name>
    <description>Dressing change 3 times per week</description>
    <arm_group_label>NPWT system</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NPWT system</intervention_name>
    <description>3 dressing changes/week for maximum 4 weeks.</description>
    <arm_group_label>NPWT system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Diabetic foot ulcers (DFUs) including post amputation wounds associated with diabetes
             suitable for Negative Pressure Wound Therapy according to the investigator's judgment

          2. 1 cm2 ≤ Wound size ≤ 200 cm2

          3. Male or female, 18 years and above

          4. Signed Informed Consent Form

          5. Subject understands the written subject Information

        Exclusion Criteria:

          1. Need for frequent dressing changes, i.e.&lt;72 hours between the changes

          2. Dry wounds

          3. Critical ischemia (for wound healing) according to investigator's judgement

          4. Malignancy in the wound and/or wound margin

          5. Target ulcer previous not successfully treated with NPWT within 48 hours

          6. Poorly controlled diabetes according to investigators judgement.

          7. Osteomyelitis which has been left untreated

          8. Infection which has been left untreated

          9. Unexplored fistula

         10. &gt; 10% surface area necrotic tissue with eschar present after debridement

         11. High risk for bleeding complications

         12. Exposed major blood vessels, organs or nerves

         13. Current or within 3 months treatment with chemotherapy or irradiation

         14. Known hypersensitivity to the dressing material

         15. Expected technically impossible to seal the film to maintain a vacuum for treatment

         16. Expected non compliance with the Clinical Investigation Plan

         17. Pregnancy

         18. Subjects not suitable for the investigation according to the investigator's judgement

         19. Subjects previously included in this investigation

         20. Subjects included in other ongoing clinical investigation at present or during the
             past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gerard Stansby, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Freeman Hospital, Newcastle upon tyne</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle upon Tyne,</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norfolk &amp; Norwich University Hospital</name>
      <address>
        <city>Norfolk,</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2009</study_first_submitted>
  <study_first_submitted_qc>November 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 11, 2009</study_first_posted>
  <results_first_submitted>December 22, 2010</results_first_submitted>
  <results_first_submitted_qc>March 20, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 21, 2012</results_first_posted>
  <last_update_submitted>March 20, 2012</last_update_submitted>
  <last_update_submitted_qc>March 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetic foot ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Investigation period: Feb 2010 - July 2010. In- and/or out-patients at two centers in UK were included in this investigation. Subjects included were 18 years and above with DFU including post amputation wounds associated with diabetes.Dressing changes were made 3 times/week for maximum 4 weeks.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Negative Pressure Wound Therapy System</title>
          <description>The Avance NPWT system is intended to help promote wound healing, including drainage and removal of infectious material or other fluids, under the influence of continuous and/or intermittent negative pressure. Avance NPWT system is designed to be used for a wide range of wounds which are suitable for NPWT.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>NPWT System</title>
          <description>Negative Pressure Wound Therapy</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Change in Wound Area.</title>
        <description>Measured by tracing of wound and measured by planimeter.</description>
        <time_frame>From baseline to maximum 4 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>NPWT System</title>
            <description>Negative Pressure Wound Therapy</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Change in Wound Area.</title>
          <description>Measured by tracing of wound and measured by planimeter.</description>
          <units>cm2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-33.7" lower_limit="-82" upper_limit="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>NPWT System</title>
          <description>Negative Pressure Wound Therapy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhoea+nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Developed MRSA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Ulceration plantar aspect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Further deterioration of wound</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>VAC could not maintain suction as surrounding skin deteriorated and seal could not be maintained</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Wound deteriorated</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Further revision required fourth toe Ulceration plantar aspect</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The Coordinating Investigator will be the lead author for the mail (primary) publication from this Investigation. For any abstract and/or manuscript the Investigators will be given at least 14 days review time before the intended submission of the document.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jenny Thorell</name_or_title>
      <organization>Mölnlycke Health Care AB</organization>
      <phone>0046 31 7223000</phone>
      <email>jenny.thorell@molnlycke.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

